Form 4: Achieve Life Sciences CEO Sells Shares After PRSU Vesting

Achieve Life Sciences CEO Richard Stewart acquired common stock through PRSU settlement and subsequently sold a portion to cover tax obligations.

Summary

• Richard Stewart, Chief Executive Officer and Director of ACHIEVE LIFE SCIENCES, INC. (ACHV), reported transactions involving the company's common stock.
• Acquired 297,500 shares of common stock on September 18, 2025, upon the settlement of Performance Restricted Stock Units (PRSUs).
• Sold 129,501 shares of common stock on September 18, 2025, at a weighted average price of $2.92 per share.
• The sale was conducted to satisfy income tax withholding and remittance obligations related to the net settlement of the PRSUs.
• The shares were sold in multiple transactions with prices ranging from $2.83 to $3.02 per share.
• Following these transactions, Stewart directly beneficially owns 228,875 shares of common stock.
• Indirect beneficial ownership includes 359 shares by spouse and 882 shares by Ricanto Limited, where Stewart is the principal owner.
• The settled PRSUs included 140,000 units with an expiration date of January 22, 2028, and 157,500 units with an expiration date of January 13, 2029.
• Each PRSU represents a contingent right to receive one share of common stock upon the achievement of specific milestones.

Sentiment

Score: 5

Explanation: The transactions are routine for executive compensation (PRSU vesting and tax-related sales) and do not indicate a significant positive or negative shift in company fundamentals or management's view. The sentiment is neutral.

Positives

• The vesting of Performance Restricted Stock Units (PRSUs) indicates that certain performance milestones set by the company were achieved, which is a positive sign for operational execution.

Negatives

• The sale of shares by a CEO, even for tax purposes, can sometimes be perceived negatively by the market, though it is a common and routine practice for equity compensation.

Future Outlook

The filing indicates that Performance Restricted Stock Units (PRSUs) vest upon the achievement of certain milestones, implying that the company has set and met specific performance targets. However, no explicit forward-looking statements or guidance regarding future company performance are provided.

Industry Context

This Form 4 filing details an insider transaction, which is specific to the reporting person and the company. It does not provide broader industry context or trends.

Related Party Transactions

• Indirect beneficial ownership includes 359 shares held by the reporting person's spouse.
• Indirect beneficial ownership includes 882 shares held by Ricanto Limited, of which the reporting person is the principal owner.

Stakeholder Impact

• Shareholders: The routine nature of the insider transaction (PRSU vesting and tax-related sale) is unlikely to have a significant impact on shareholder sentiment or the company's valuation. While a sale by a CEO could be viewed negatively, the stated reason for tax obligations mitigates this concern.
• Employees, customers, suppliers, creditors: No direct impact on these stakeholders is indicated by this specific filing.

Key Dates

Keywords

Achieve Life Sciences, ACHV, Richard Stewart, Form 4, insider trading, stock sale, PRSU, restricted stock units, CEO, director, common stock